Acusphere Overview
- Year Founded
-
1993
- Status
-
Out of Business
- Employees
-
118
- Latest Deal Type
-
Out of Business
Acusphere General Information
Description
Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.
Contact Information
Website
www.acusphere.comCorporate Office
- 99 Hayden Avenue
- Suite 385
- Lexington, MA 02421
- United States
Corporate Office
- 99 Hayden Avenue
- Suite 385
- Lexington, MA 02421
- United States
Acusphere Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Out of Business | 05-Mar-2018 | Completed | Out of Business | |||
| 12. PIPE | 16-Feb-2012 | Completed | Generating Revenue | |||
| 11. PIPE | 31-Aug-2006 | Completed | Generating Revenue | |||
| 10. PIPE | 25-Oct-2004 | Completed | Generating Revenue | |||
| 9. IPO | 08-Oct-2003 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series J) | 01-Jun-2002 | Completed | Startup | |||
| 7. Later Stage VC (Series I) | 01-Jun-2001 | Completed | Startup | |||
| 6. Later Stage VC (Series F) | 01-Sep-2000 | Completed | Startup | |||
| 5. Later Stage VC (Series E) | 01-Oct-1998 | $2.5M | $25.5M | Completed | Startup | |
| 4. Later Stage VC (Series D) | 01-Nov-1997 | $10.2M | $23M | Completed | Startup |
Acusphere Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series J | ||||||||
| Series I | ||||||||
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | $1.000000 | $1.6 | $1.6 | 1x | $1.6 | 7.36% | ||
| Series A | $1.000000 | $1 | $1 | 1x | $1 | 2.52% |
Acusphere Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Acusphere Patents
Acusphere Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2011140527-A | Dosage formulation of ultrasound contrast agent | Inactive | 20-Apr-2011 | ||
| US-20100062066-A1 | Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration | Inactive | 14-Nov-2006 | ||
| CA-2631492-A1 | Processes for making particle-based pharmaceutical formulations for oral administration | Inactive | 15-Dec-2005 | ||
| US-20070148211-A1 | Processes for making particle-based pharmaceutical formulations for oral administration | Inactive | 15-Dec-2005 | ||
| DE-602006009710-D1 | Method for the production of pharmaceutical formulations on particle basis for parenteral administration | Active | 15-Dec-2005 | A61K9/0019 |
Acusphere Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Acusphere FAQs
-
When was Acusphere founded?
Acusphere was founded in 1993.
-
Where is Acusphere headquartered?
Acusphere is headquartered in Lexington, MA.
-
What is the size of Acusphere?
Acusphere has 118 total employees.
-
What industry is Acusphere in?
Acusphere’s primary industry is Pharmaceuticals.
-
Is Acusphere a private or public company?
Acusphere is a Private company.
-
What is Acusphere’s current revenue?
The current revenue for Acusphere is .
-
How much funding has Acusphere raised over time?
Acusphere has raised $154M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
